Related Experiment Videos
[Right ventricle myocardial infarction from personal observations]
S Słowiński1, P Moszczyński, B Januś
1Oddziału Kardiologicznego Wojewódzkiego Szpitala Zespolonego im. E. Szczeklika w Tarnowie.
Przeglad Lekarski
|September 24, 1999
Summary
Right ventricle myocardial infarction, often accompanying inferior myocardial infarction, occurs in 5.4% of patients. Early diagnosis using V3R-V5R ECG leads and fibrinolytic therapy improve outcomes, making this diagnosis crucial for specific patient treatment.
Area of Science:
- Cardiology
- Electrocardiography
- Internal Medicine
Context:
- Right ventricle myocardial infarction (RVMI) is a critical condition often associated with left ventricle myocardial infarction (LVMI).
- Diagnosis relies on specific electrocardiographic leads (V3R-V5R), particularly in cases of inferior LVMI.
- Understanding RVMI prevalence and outcomes is essential for effective patient management.
Purpose:
- To determine the incidence and characteristics of right ventricle myocardial infarction in a large patient cohort.
- To investigate the association between RVMI and inferior myocardial infarction.
- To evaluate the impact of treatment, including fibrinolytic therapy, on hospital mortality in RVMI patients.
Summary:
- This study analyzed 2514 myocardial infarction patients, identifying 147 cases (5.4%) of RVMI between 1991-1997.
- RVMI most frequently coexisted with inferior myocardial infarction (10.7%).
- Hospital mortality was 6.8%, with cardiogenic shock as the primary cause of death; fibrinolytic therapy was linked to lower mortality.
Impact:
- The findings underscore the necessity of V3R-V5R ECG lead monitoring for all acute myocardial infarction patients.
- Accurate RVMI diagnosis is vital for implementing specific, potentially life-saving treatments.
- The study provides valuable data on RVMI, contributing to improved clinical guidelines and patient care.